News – Page 913 – Endpoints News

SIGN UP

Bayer’s $240M upfront for BlueRock acquisition puts them in the high rollers club for preclinical biotech buyouts

6 years ago

CMS will now cover pricey CAR-T therapies for Medicare patients

6 years ago

Bayer is going all in on next-gen stem cell biotech BlueRock, buying out Versant and founders for $600M

6 years ago

Gilead's newly departed R&D chief re-emerges as CEO of a rival hep B biotech looking to make a comeback

6 years ago

Loxo chief Josh Bilenker steps in (temporarily) to head oncology R&D at Eli Lilly as Levi Garraway steps out

6 years ago

Athenex's oral chemotherapy formulation scores in pivotal study; Glycomine brings in $33M in Series B haul

6 years ago

Permira proposes to take Cambrex private in $2.4B deal, stirring up CDMO M&A

6 years ago

Teva to lose CFO, with turnaround still under construction

6 years ago

What’s a late-stage IL-23 drug worth these days? We’re about to find out

6 years ago

Part procedure, part drug: Robert Ang joins Siddhartha Mukherjee in pioneering a new type of cell engineering

6 years ago

AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race

6 years ago

Rhythm Pharmaceuticals' lead drug scores in pivotal rare obesity trials

6 years ago

Faced with another ethics scandal, Novartis CEO Vas Narasimhan assures analysts they tried to do 'the right thing'

6 years ago

Under a cloud of opioid lawsuits, Mallinckrodt suspends specialty generics spinoff

6 years ago

FDA endorses Novavax's pivotal trial design for flu vaccine; Forty Seven bags funding for myelodysplastic syndromes ...

6 years ago

Biotech startup joins quest to harness microbiome to untether reliance on antibiotics in women's health

6 years ago

Gilead faces a hurdle in its race for big, add-on OK for Descovy as generic Truvada rivals loom

6 years ago

GlaxoSmithKline drops out of Ebola vaccine development as R&D shifts resources to franchise drugs

6 years ago

Sanofi, Regeneron post back-to-back wins with new OK and a fresh round of positive PhIII data for their blockbuster ...

6 years ago

Neoleukin's quest to shake up the IL-2 space gets a boost via reverse merger with Aquinox

6 years ago

In draft guidance, NICE fails to back Clovis's PARP inhibitor Rubraca

6 years ago

Guardant blood test shows promise in predicting immunotherapy response; AstraZeneca's diabetes drug wins EU label ...

6 years ago

Takeda kicks up GPCR work with Sosei Heptares, dishing out $26M to get GI drug discovery going

6 years ago

Tiny Sienna is calling in Cowen as shares continue to languish long after a severe trial setback

6 years ago

First page Previous page 910 911 912913914 915 916 Next page Last page